Related Experiment Video
Updated: May 16, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Natural history of acute and chronic hepatitis C
Benjamin Maasoumy1, Heiner Wedemeyer
1Hannover Medical School, Carl-Neuberg-Str.1, 30625 Hannover, Germany.
Insights
Hepatitis C virus (HCV) infection causes significant liver disease and extra-hepatic issues. Understanding individual risk factors is key for personalized, effective treatment, even with new interferon-free therapies.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis C virus (HCV) infection is a significant global health concern, leading to liver disease, decompensation, and hepatocellular carcinoma.
- Extra-hepatic manifestations are common in HCV infection, complicating patient outcomes.
- Significant variability exists in HCV disease progression due to host, viral, and environmental factors.
Purpose of the Study:
- To better define the contribution of distinct risk factors to disease progression in different phases of HCV infection.
- To emphasize the need for personalized treatment strategies in the era of interferon-free therapy.
- To highlight the importance of risk profiling for avoiding under- or over-treatment of HCV.
Main Methods:
- This study is a review and synthesis of existing literature on HCV.
- Analysis of host, viral, and environmental factors influencing HCV natural history.
- Evaluation of treatment outcomes and risk stratification models.
Main Results:
- Interindividual variability in HCV natural history is substantial.
- Host, viral, and environmental factors significantly influence disease progression.
- Antiviral treatment can prevent complications, but risk factor definition is incomplete.
Conclusions:
- Personalized treatment approaches for HCV are crucial.
- Individual risk profiles should guide therapy to optimize outcomes and prevent complications.
- Accurate risk assessment remains vital for effective HCV management, particularly with emerging interferon-free treatments.
Abstract:
Hepatitis C virus (HCV) infection remains a major global health burden. Hepatitis C causes significant liver-related morbidity and mortality due to hepatic decompensation and development of hepatocellular carcinoma. In addition, extra-hepatic manifestations of hepatitis C are frequent. There is a very large interindividual variability in the natural history of both acute and chronic hepatitis C which can be explained in part by a combination of various host, viral and environmental factors. Successful antiviral treatment can prevent short- and long-term complications of HCV infection in many patients. Still, the relative contribution of distinct risk factors for disease progression in different phases of HCV infection needs to be better defined. Personalized treatment approaches for HCV infection should consider individual risk profiles to avoid both under- and over-treatment - which will remain important also in upcoming era of interferon-free treatment of hepatitis C.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

